Fasting-mimicking diet plus chemotherapy in breast cancer treatment

Claudio Vernieri (), Francesca Ligorio, Emma Zattarin, Licia Rivoltini and Filippo Braud
Additional contact information
Claudio Vernieri: Fondazione IRCCS Istituto Nazionale dei Tumori
Francesca Ligorio: Fondazione IRCCS Istituto Nazionale dei Tumori
Emma Zattarin: Fondazione IRCCS Istituto Nazionale dei Tumori
Licia Rivoltini: Fondazione IRCCS Istituto Nazionale dei Tumori
Filippo Braud: Fondazione IRCCS Istituto Nazionale dei Tumori

Nature Communications, 2020, vol. 11, issue 1, 1-4

Abstract: A clinical trial published in Nature Communications examined the effect of fasting-mimicking diet (FMD) during chemotherapy in breast cancer patients. The overall negative study results highlight the need for ameliorating future trial design and investigating alternative FMD-based therapeutic combinations.

Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41467-020-18194-1 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-18194-1

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-020-18194-1

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().